 |
J&J in takeover talks with $20bn biotech firmUS-based Johnson & Johnson (J&J), a global healthcare company said it was in preliminary talks with Actelion Pharmaceuticals about a potential takeover of Europe's largest biotech firm, currently valued at about $20 billion, a report More… |
 |
Johnson & Johnson forms JV with Al NaghiJohnson & Johnson Middle East has announced the establishment of Johnson & Johnson Consumer Saudi Arabia Limited, a locally registered legal entity, resulting from a joint venture between the company and Ahmed Mohammed Abdel Wahab Naghi More… |
 |
Carlyle to buy Johnson & Johnson unit for $4bnPrivate equity firm Carlyle Group is nearing an agreement to acquire Johnson & Johnson's ortho clinical diagnostics unit, four people familiar with the matter said, in a deal expected to be worth around $4 billion. Carlyle More… |
 |
J&J to pay $2.2bn to end US drug probesIn one of the largest health care fraud settlements in US history, Johnson & Johnson will pay $2.2 billion to end civil and criminal investigations into kickbacks to pharmacists and the marketing of pharmaceuticals for off-label uses, US Att More… |
 |
Johnson & Johnson recalls Cilest birth control pillsJohnson & Johnson is voluntarily recalling about 32 million packages of its birth control pill Cilest in Europe, Asia and Latin America, a spokeswoman said late on Tuesday, the latest in a string of recalls over the past two years. More… |
 |
J&J to buy Swiss medical firm for $20bnJohnson & Johnson is in preliminary talks to acquire Swiss medical device maker Synthes for a price which could be about $20 billion, a source familiar with the situation said on Saturday. A deal at that price would mark an 11 per cent More… |
 |
J&J to cut 6-7pc of workforceJohnson & Johnson will eliminate about 6 percent to 7 percent of its global workforce, or some 7,000 to 8,000 positions, as the diversified healthcare company restructures and seeks cost savings, the company said on Tuesday. The compan More… |
 |
J&J, nonprofit in TB drug tie-upHealthcare company Johnson & Johnson said on Wednesday it has joined with the nonprofit Global Alliance for TB Drug Development to speed commercialisation of its experimental tuberculosis drug, known as TMC207. The drug, designed to in More… |
 |
China clears Johnson & Johnson productsChinese health authorities said on Saturday that they had found no evidence of cancer-causing chemicals in baby products made by US company Johnson & Johnson. The State Food and Drug Administration had investigated 33 products, includi More… |
|
Johnson & Johnson products safe says ChinaChinese health authorities said on Saturday that they had found no evidence of cancer-causing chemicals in baby products made by US company Johnson & Johnson. The State Food and Drug Administration had investigated 33 products, includi More… |
